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The concept of multitest screening for hematological disorders is not necessarily a new one. Implementation of such ideas has recently become possible,
for the automated electronic instruments performing sequential multiple analyses within very short
periods of time are a very significant advancement
in the technology of the hematology laboratory. It
must be emphasized, however, that the value of such
instrumentation lies not only in the rapidity, but also
in the accuracy and precision as well as the number
and nature of the tests performed. While the data on
samples have been reported on individual patients
three and a half years in our hematology laboratory,
it is only within the past few months that examples
of its utilization for screening studies have begun to
appear in the literature (1, 3, 5) .
Several automated instruments are available
that perform the routine counting and sizing of cells
in the blood. The Coulter model "S" is the one most
widely used ( 2) . This is the instrument we use and
it is the one used in the studies to be cited here. It
is an instrument that reports on seven parameters,
measuring the WBC, RBC, and mean corpuscular
volume (MCV), and utilizing the latter two computing the hematocrit and then the mean corpuscular
hemoglobin (MCH) and mean corpuscular hemoglobin concentration (MCHC). The time required
from the time of sample aspiration until the results
of the seven determinations are printed is 40 seconds.
I must emphasize that not only speed is achieved,
but precision and accuracy are far greater than many
previously used methods. Indeed, variation on replicate samples is less than 1 % and accuracy appears
to be of the same order.
Considering the availability of such accurate
data and the comparative ease with which they may
be obtained, it can be seen that these instruments
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can be valuable tools in screening for hematological
abnormalities. Indeed here at the Medical College
of Virginia, two interdepartmental cooperative
studies have been conducted within the past year.
One of these was presented in abstract form at the
December 1972 meeting of the American Society
of Hematology, and has recently been submitted for
definitive publication (5). The work in large part
was the project of Mr. Alvin Schmaier, currently a
third-year medical student, with assistance from Drs.
Maurer, Johnston and Scott. The other study has
been conducted as part of a larger study in approximately 530 Black children in the Head Start Program. These studies exemplify particularly well the
principle of multitest screening in hematology, and
it is to these and to a comparison of these with
previous studies (1, 3) that I wish to address myself.
I will not detail the technical operation of the
model "S" but note here that we have had the instrument in operation for more than three and a half
years. This has given us extensive experience in all
of the positive as well as the negative qualities of
the instrument. Because some of the parameters are
computed, our initial efforts were to compare these
with other methods then in operation and standardize
the data. This was accomplished by comparative data
obtained on 1,500 samples of EDTA anticoagulated
blood. No significant difference was found in the
hemoglobin determination, but the linearity was better in the model "S" determinations than with flowthrough determinations giving greater accuracy to
the former, particularly in the high > 16 gm and
low < 7 gm ranges. For reasons which have never
been satisfactorily explained either by us or by the
manufacturer, the WBCs average approximately
8 % lower by the model "S" than when determined
by our alternative or electronic back-up. This discrepancy is noted also in data from other institutions. The lower percentage has been consistent
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and therefore is not a factor. Finally, the comparison of the spun hematocrit with the computed
hematocrit (MCV x RBC) showed the latter to
be, on the average, 1 % higher-a difference that
is minimal and one that certainly can be disregarded. I should note here that this is somewhat
different from the study of England and Fraser
( 1) who set the electronics so that the hematocrit is 1.5% below the spun hematocrit. This
quite possibly might allow for differences of our
MCV norm 92 ± 6 (range 86-98) from theirs
(80-90). Indeed Pearson, et al. ( 3), describe a
range of 72-101 with a mean of 88.67 and a standard deviation of 5.3.
At the outset then, it becomes important to note
what the norms are for the population being studied
and these should be norms for the institution. The
data just given are presumed to be an adult population; however, it is not clear from either of the published reports cited above whether age differences
were taken into consideration in their studies. The
reason for concern with the age variability of the
MCV data will become apparent since this parameter
is one of the major criteria used to screen for the
thalassemia syndromes.
The other measured parameter of extreme importance in the screening efforts is the RBC. We
have come to regard this as extremely accurately
measured by the model "S." In contrast to the
earlier manual methods with an accuracy no greater
than 20 % , we now feel the accuracy and reproducibility of this measurement is on the order of
1 % , or in the range of 50,000 RBC/µl.
With these points in mind, I would like to discuss the application of multitest screening in hematology and share some of the results we have accumulated in specific studies. The first such study
undertaken here was a cooperative effort involving
the divisions of Clinical Pathology, Pediatrics and
Medicine. Mr. Alvin Schmaier, working as a summer
extern in the Department of Pediatrics, was responsible for the collection of samples anti collation of
the data. This portion of my report is in large part
his effort. It is a most commendable piece of work
which recently has been submitted for publication ( 5). The data given here are reproduced with
his permission.
This study took advantage of the fact that defective alpha chain synthesis may occur in the neonate
and result in the presence of the tetrameric hemoglobin, hemoglobin Barts (gamma 4). This form of
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hemoglobin rapidly disappears with onset of beta
chain synthesis and by six months of age no longer
can be identified. Cord blood studies have been performed but these naturally are limited in scope.
Alpha thalassemia heterozygotes have abnormal red
cell indices, and if these could be identified early, it
might be possible to select infants in the neonatal
period, or certainly within the first few weeks of
life, whose blood then could be subjected to hemoglobin electrophoresis.
Taking advantage of the fact that blood could
be obtained by capillary puncture with the use of
unopettes from Becton Dickinson especially for
model "S" counters ( order no. 5840, Becton Dickinson, Rutherford, N. J.), Mr. Schmaier began collecting capillary samples in triplicate from the newborn nursery, of course after receiving parental
consent. Table 1 shows the tabulation of the results.
In particular, I want to call attention to the MCV
and MCH. If one were to choose values for identification as suggested by other studies, one would
select only those with values below 80 fl! Obviously,
then the norm for this population group is quite different from adults, a fact that is well known ( 6).
We were unaware, however, of the limits using the
model "S" and these needed definition for the study.
A total of 200 newborn Black infants was
studied. Electrophoresis of the hemoglobin in these
newborns showed 181 to be normal; that is, only
hemoglobins A and F. Of the remainder, 13 showed
an additional abnormal hemoglobin either S or C,
while six showed the presence of hemoglobin Barts.
Of the six, one also showed C and one S hemoglobin.
As defined in Table 1, the lower limit of normal was
97 fl. In the samples studied, nine infants had MCV
less than 94 fl and MCH less than 29.5 fl. Since
these figures are less than normal the data would be
"suspect" and thus hemoglobin electrophoresis was
performed. In the group of 200 studied, all had
hemoglobin electrophoresis performed. Table 2
shows the hemoglobin electrophoresis and pertinent
model "S" data on those with abnormal MCV and
MCH. It is to be noted that hypochromia can no
longer be assessed by the MCHC ( 4); that is clearly
shown in this table. The most s·triking findings are
that of nine patients, six had hemoglobin Barts and
thus the alpha thalassemia trait. These were clearly
identified by the low MCV and low MCH. Two of
the patients had a second abnormality in that Hgb C
was identified in one and S in the other. In the total
sample, 13 infants were identified who had either
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TABLE 1
RED CELL INDICES IN NORMAL BLACK FULL-TERM NEWBORN INFANTS

Red Blood Cell Count ( X 10 6 / µI)
Hemoglobin (g / dl)
Hematocrit ( % )
Mean Corpuscular Volume (fl)
Mean Corpuscular Hemoglobin (pg)
Mean Corpuscular Hemoglobin Concentration (g/dl)

Mean

Standard Deviation

ks

lower Tolerance Limit

5.2
18.0
55.3
106.4
34. 5
32.5

0.6
2.0
6.1
5.7
2.2
1.0

1.0
3.3
10.0
9.4
3.6
1. 7

4.2
14.7
45.3
97.0
30.9
30.8

s = Standard Deviation
Constant k = L65
Lower tolerance limit = mean-ks
Sample size == 91
For example, for the mean corpuscular volume of 106.4µ 3 , the lower limit of normal is 97µ 3 (lower tolerance limit).

Hgb Sor C but no Barts and an MCV and MCH
within the normal limits. Thus in this study, all
infants with alpha thalassemia were readily identified
so that no "false negative" values were recorded.
There apparently were three false positives, with
data just below the norms set. Currently, there is no
explanation for these.
It can be seen then that Mr. Schmaier made
a significant contribution in the study and that it
is possible to screen infants using the multitest
principle. As a matter of fact, the incidence of
3 % hemoglobin Barts is consistent with the reported incidence in American Blacks.

Let me now turn to another study involving
muHitest screening with the evaluation of RBC
abnormality indices. Whereas the previous study
was concerned with alpha thalassemia trait, this
study was designed to study thalassemia traits perhaps encompassing both alpha and beta thalassemias. Again, this was a cooperative study involving the same divisions as those in the study
just cited.
The group screened was quite different, however. This was composed of 540 Black children
most of whom were enrolled in the Head Start
Program in Richmond. Our study was only part

TABLE 2
HEMATOLOGIC FINDINGS IN NINE INFANTS WITH MEAN CORPUSCULAR VOLUMES < 94 FL
AND MEAN CORPUSCULAR HEMOGLOBINS <29.5 PG
Infant
1
2
3
4
5
6
7
8
9

Hgb Pattern
F, A,
F, A,
F, A,
F, A,
F, A,
A, F,
F,A
F,A
F, A

S, Barts
C, Barts
Barts
Batts
Barts
Barts*

MCV (fl)

MCH (pg)

MCHC (gm/di)

Hgb Barts ( % )

Other Abnormal Hgb ( % )

93
93
87
94
93
90
91
93
91

28.5
28.2
27.7
29.1
29 . 5
28 .0
29.0
29.2
29 . 3

31.0
30. 7
32 . 0
31.4
32.1
31. 6
31.2
31.4
32.2

4.6
4.4
5. 1
6. 6
4.8
3.0

4.8
10. 6

MCV = mean corpuscular volume
MCH = mean corpuscular hemoglobin
MCHC = mean corpuscular hemoglobin concentration
RBC = red blood cell count
Hgb = hemoglobin
Hct = hematocrit
* Electrophoretic pattern at one month of age
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of a larger medical evaluation conducted under
the aegis of the Department of Pediatrics at the
Medical College of Virginia. As part of the study,
capillary blood samples were drawn by a registered
medical technologist at the various schools. Samples
were takep. for Coulter model "S" determinations
and hemoglobin electrophoresis. As in the earlier
study, unopettes for the model "S" (order no. 5840,
Becton Dickinson, Rutherford, N. J.) were used.
These were drawn in duplicate, the model "S"
parameters determined on both samples. Capillary
sampks also were used for the hemoglobin electrophoresis. Indices available for comparison were
dated prior to the advent of electronic counters
performing multiple simultaneous tests. Our experience with initial standardization of our model
"S" showed that our norm for the automated procedures of 92 ± 6 was higher than that generally
used · of 88 .± 8. It seemed likely, therefore, tqat
these older data could represent values lower tqan
might be obtained by the currently used automated
methods. Additionally, other than the standards
cited by Shumway (6), I am aware of no others.
As a result, it seemed preferable to determine our own
mean model "S" parameters for this age group.
As noted, the recently published works did
not specify the ages of the patients studied. It was
assumed, therefore, that these were adults. In both
studies, the lower limit of normal was 80. With
Shumway's data ( 6) suggesting a lower mean MCV
for pediatric age groups when compared with adults,
we felt that perhaps it would be wise to include
lower values. Thus for those studies, an MCV of 76
or greater was used for establishment of the mean
and those 75 or lower were excluded. It is gratifying
to note that 26% of the children studied had MCVs
76-79 and would have been excluded if the criteria
of other screening studies had been used.
For the moment, I would like to refer to the
results not as normal but rather as "mean model
'S' parameters." The health of the children was
not evaluated and the sampling was random. Data
from two children were excluded because of hemoglobin values less than 10 but with MCV over 80.
As a result, determination on 451 Black
children, ages four to eight, with MCV greater than
76 were available for analysis. The results of these
determinations are shown in Table 3. As noted,
these are mean model "S" parameters for the group
studied. These show the means with one standard
deviation as well as the range. Also shown is the

TABLE 3
MEAN MODEL "S" PARAMETERS
(451 Black Children MCV > 75)

Determination

Mean± SD

Range

Lower
Toi. Limit*

RBC
Hgb
Hct
MCV
MCH
MCHC

4.51 ± 0.31
12.3 ± 0.86
36.7 ± 2.4
81.8 ± 3.3
27. 3 ± I. 3
33.7±0. 8

3.81-5.19
10.4- 14.8
31.1-45.1
76.0-91.0
24 . 3-31. 3
31. 9-35. 7

4.0
10.9
32.7
76.4
25 . 2
32 . 4

* Lower Tolerance Limit

= x - ks
mean
k = 1.65 (95 % tolerance level)
s = standard deviation

x

=

lower tolerance limit using a 95 % tolerance interval (k = 1.65) . With these figures we could
be 95 % certain that 90% of the values would be
above the lower tolerance limit shown in the right
hand column.
It now becomes of great interest to compare
these results with those alluded to earlier as having
been determined by nonautomated methods and
reported by Shumway ( 6). This comparison is
shown in Table 4. The similarities are remarkable,
especially when one considers that our population
sample was not a selected one and was from children with Hgb greater than 10.4 gms and MCV
76 or greater. I think we can conclude that it might
be reasonable to accept these as normal values for
the age group.
Our original intent for the determination of
the indices was to see if it would be possible to
screen for thalassemia trait using microcytic hypochromic indices as the major criteria. The spectre
of iron deficiency, however, loomed large in front
of us since both thalassemia trait and iron de-

TABLE 4
Current Data
RBC
Hgb
Hct
MCV
MCH
MCHC

4 . 51 ± 0.31
12.3 ± 0 . 86
36 . 7 ± 2.4
81.8 ± 3.3
27. 3 ± I. 3
33.7±0.8

Shumway (6)
4.65
12 . 7
37 .0
80.0
27.0
34.0

±
±
±
±
±
±

.5
1
3
4
2
1
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ficiency are characterized by microcytic hypochromic
indices. At the time that these data were being collated for presentation, the results of the
hemoglobin electrophoresis were not available.
Thus, there were 84 children with MCV 75 or
less who needed to be differentiated if possible.
Pearson, et al. (3), in their studies, proposed a
scheme for thalassemia trait screening. This is shown
in a slightly modified fashion in figure 1. Note that
the first step in screening is to classify the subjects
into two groups according to the MCV which is
precisely what we did. The next step involves
quantification of A.2 hemoglobin which, as noted,
is not at the moment available.
This led to a search for an alternative method
for attempting to differentiate the MCV 75 and
below group. Recently, such a method has been
published by England and Fraser ( 1). They reported that by the use of the statistical discriminant
function (D.F .) they were able to differentiate between ·the disorders with a 99% success rate in
72 cases. As a result of their study, a slightly modified formulation is available and is shown as well
as the data for the study in Table 5. Thus, it seemed

MCV (Model "S")

MCV < 79 fl

~~

MCV >79 fl

that it might be possible to predict, in advance of
the receipt of the electrophoretic data, the groups
into which our 84 subjects might fall and effectively
separate the thalassemia trait from an iron deficiency. Accordingly, the appropriate data on those
children with MCV 75 or less were substituted
into the formula. The results are shown along with
the normal in Table 5. It can be seen that 11 of
the group had negative, while 73 had positive, D.F.s.
To show the distribution, a chart like that of England and Fraser ( 1 ) was prepared and is shown
in figure 2. The closed circles represent those subjects with a positive D.F.' and presumable iron deficiency. Those with the open circles represent the
negative D.F.' and presumable thalassemia trait.
Since the critical data currently are missing, I think
it is only possible to state that we are predicting
that these are the groups into which the subjects
fall. The data in Table 5 show certain of the mean
values to be sufficiently different to suggest that these
really are two distinct groups despite a few (four)
that were too close to O to call ( fig. 2). As soon as
the additional data are available, we will know how
well we are able to predict.
If I may be allowed to speculate, I expect a
high success rate. As evidence for this rather rash
statement, again direct your attention to figure 2.
Note that in the D.F.' negative area [D.F.' =
MCV -RBC - (5 x Hgb) - 3.4] there are
four x's. While this manuscript was in preparation,
I noted four patients' model "S" data that were
quite like those seen in the 11 children with negative D.F.s. I felt these were suspect on the basis

Dx: Normal
TABLE 5
Hgb A,> 3.5%
Dx:

f)

COMPARISON OF GROUPS

3.5%

t

t

Thalassemia

# of
Children

Serum iron

/

Normal
+ family study

i

451

\

BY

MCV AND D.F.'*

11

73
MCV < 76

Reduced
MCV > 75
Dx: Iron deficiency

Dx : a Thalassemia

Modified from Pearson, et al (3).

RBC
Hgb
Hct
MCV
MCH
MCHC
* D.F.'

Fig. I- Suggested schema for thalassemia trait screening.

4. 51±0.31
12.3±0.86
36.7 ± 2. 4
81.8±3.3
27.3 ± 1.3
33.7±0.8
=

D.F.'*5.54±0.19
12.5 ± 0 . 67
37. 7 ± 1. 79
*68.4 ± 3. 8
*22.6±1.75
33 . 3 ± 1.03

D.F.'+
4.86 ± 0 . 28
11.6 ± 0. 70
35.2±2.14
*72.9 ± 2.57
*24.0 ± 1.15
33 . 1 ± 0.93

MCV - RBC - (5 X Hgb) - 3.4
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Figure 2

>11
+10

+8

+6

+4

+2

TABLE 6

··-··········

•

•

• •
••
•
•
•
•
• • • •
• •
• •
•• • • • •
• • •
••
• • •
• • • •• •
••••
•••
•
• • •
•
• •• • • • •
..................................
•
................................
~

•

•
0

0

.....................................................................
0

-2
0

0

X (6.0%)

0

-4

0

MCV

MCH

D .F.

% A,Hgb

D.H.
W.F .
A.J.
P.F.

5.65
6.52
6.17
6.16

62
64
65
64

20
20
21
20

-3 .05
-9.92
-8.5
-6.5

6
6
7
(*)

* Elevated above normal- not quantified

to select those most likely to have beta thalassemia
trait. I await with eagerness complete collation of
data, predictions and electrophoresis in the 84
children noted.
In summary, it can be said that a sample of
multitest screening in hematology has been presented, made possible by the use of automated
counting apparatus. The ease, precision and accuracy of the determinations favor much wider
application. To this end studies are now cropping
up in the literature, almost with every new journal
that hits one's desk. Our efforts presented here show
that studies of "at risk" populations are not only
feasible but practical. Such examples as those given,
certainly advance our knowledge and facilitate our
know-how in difficult diagnostic areas.

0
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X (6.0%)

D.F. = MCV - RBC - (5 x Hgb) - 3.4
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of the experience I was accumulating. Hemoglobin
electrophoresis was performed in these, therefore,
and the A 2 hemoglobin quantified. Summary data
on these patients are given in Table 6. Such ability
to predict certainly suggests that the automated
multitest apparatus has given us remarkable ability

I. ENGLAND, J. M. AND FRASER, P. M . Differentiation of
iron deficiency from thalassemia trait by routine blood
count. Lancet I :449, 1973.

2. Instruction manual for the model "S" coulter counter.
Fifth Edition. Hialeah, Florida. Coulter Electronics,
1969.
3. PEARSON, H. A., O'BRIEN, R. T. AND McINTOSH, S.
Screening for thalassemia trait by electronic measurement of mean corpuscular volume. N . Engl. I. M ed. 288:
351, 1973.

4. RosE, M. S. Epitaph for the MCHC. Br. Med. I. 4 : 169,
1971.
5. SCHMAIER, A. H., MAURER, H . M ., JOHNSTON, C. AND
Scorr, R. B. Alpha tha lassemia screening in neonates
by MCV and MCH determination. / . Ped. (In press) .

6. SHUMWAY, C. N. C hildren are different. Bulletin No. 16.
Development of the red blood cell and hemoglobin.
Ross Laboratories, Columbus, Ohio, 1968.

